Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 443

1.

High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study.

Duseja A, Acharya SK, Mehta M, Chhabra S; Shalimar, Rana S, Das A, Dattagupta S, Dhiman RK, Chawla YK.

BMJ Open Gastroenterol. 2019 Aug 7;6(1):e000315. doi: 10.1136/bmjgast-2019-000315. eCollection 2019.

PMID:
31423319
2.

Indian National Association for the Study of the Liver-Federation of Obstetric and Gynaecological Societies of India Position Statement on Management of Liver Diseases in Pregnancy.

Arora A, Kumar A, Anand AC, Puri P, Dhiman RK, Acharya SK, Aggarwal K, Aggarwal N, Aggarwal R, Chawla YK, Dixit VK, Duseja A, Eapen CE, Goswami B, Gujral K, Gupta A, Jindal A, Kar P, Kumari K, Madan K, Malhotra J, Malhotra N, Pandey G, Pandey U, Puri RD, Rai RR, Rao PN, Sarin SK, Sharma A, Sharma P, Shenoy KT, Singh KR, Singh SP, Suri V, Trehanpati N, Wadhawan M.

J Clin Exp Hepatol. 2019 May-Jun;9(3):383-406. doi: 10.1016/j.jceh.2019.02.007. Epub 2019 Mar 6. Review.

PMID:
31360030
3.

Tadalafil, a Phosphodiesterase-5 Inhibitor, Improves Erectile Dysfunction in Patients With Liver Cirrhosis.

Thakur J, Rathi S, Grover S, Chopra M, Agrawal S, Taneja S, Duseja A, Bhansali A, Chawla YK, Dhiman RK.

J Clin Exp Hepatol. 2019 May-Jun;9(3):312-317. doi: 10.1016/j.jceh.2018.07.007. Epub 2018 Aug 18.

PMID:
31360023
4.

Presence of Multidrug-resistant Infections at Admission Predict 28-day mortality in Acute Decompensation of Cirrhosis.

Gupta T, Lochan D, Verma N, Rathi S, Aggarwal S, Duseja A, Taneja S, Chawla YK, Dhiman RK.

J Gastroenterol Hepatol. 2019 Jul 23. doi: 10.1111/jgh.14788. [Epub ahead of print]

PMID:
31334860
5.

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update.

Sarin SK, Choudhury A, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Saigal S, Saraf N, Soin AS, Devarbhavi H, Kim DJ, Dhiman RK, Duseja A, Taneja S, Eapen CE, Goel A, Ning Q, Chen T, Ma K, Duan Z, Yu C, Treeprasertsuk S, Hamid SS, Butt AS, Jafri W, Shukla A, Saraswat V, Tan SS, Sood A, Midha V, Goyal O, Ghazinyan H, Arora A, Hu J, Sahu M, Rao PN, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Prasad VGM, Payawal DA, Abbas Z, Dokmeci AK, Sollano JD, Carpio G, Shresta A, Lau GK, Fazal Karim M, Shiha G, Gani R, Kalista KF, Yuen MF, Alam S, Khanna R, Sood V, Lal BB, Pamecha V, Jindal A, Rajan V, Arora V, Yokosuka O, Niriella MA, Li H, Qi X, Tanaka A, Mochida S, Chaudhuri DR, Gane E, Win KM, Chen WT, Rela M, Kapoor D, Rastogi A, Kale P, Rastogi A, Sharma CB, Bajpai M, Singh V, Premkumar M, Maharashi S, Olithselvan A, Philips CA, Srivastava A, Yachha SK, Wani ZA, Thapa BR, Saraya A, Shalimar, Kumar A, Wadhawan M, Gupta S, Madan K, Sakhuja P, Vij V, Sharma BC, Garg H, Garg V, Kalal C, Anand L, Vyas T, Mathur RP, Kumar G, Jain P, Pasupuleti SSR, Chawla YK, Chowdhury A, Alam S, Song DS, Yang JM, Yoon EL; APASL ACLF Research Consortium (AARC) for APASL ACLF working Party.

Hepatol Int. 2019 Jul;13(4):353-390. doi: 10.1007/s12072-019-09946-3. Epub 2019 Jun 6.

PMID:
31172417
6.

High prevalence of non-alcoholic fatty liver disease among healthy male blood donors of urban India.

Duseja A, Najmy S, Sachdev S, Pal A, Sharma RR, Marwah N, Chawla Y.

JGH Open. 2019 Jan 16;3(2):133-139. doi: 10.1002/jgh3.12117. eCollection 2019 Apr.

7.

Rupture of Hepatocellular Carcinoma: A Review of Literature.

Sahu SK, Chawla YK, Dhiman RK, Singh V, Duseja A, Taneja S, Kalra N, Gorsi U.

J Clin Exp Hepatol. 2019 Mar-Apr;9(2):245-256. doi: 10.1016/j.jceh.2018.04.002. Epub 2018 Apr 26. Review.

PMID:
31024207
8.

Redefining the Normal Values of Serum Aminotransferases in Healthy Indian Males.

Najmy S, Duseja A, Pal A, Sachdev S, Sharma RR, Marwah N, Chawla Y.

J Clin Exp Hepatol. 2019 Mar-Apr;9(2):191-199. doi: 10.1016/j.jceh.2018.06.003. Epub 2018 Jun 21.

PMID:
31024201
9.

Drug-Induced Acute-on-Chronic Liver Failure in Asian Patients.

Devarbhavi H, Choudhury AK, Sharma MK, Maiwall R, Al Mahtab M, Rahman S, Chawla YK, Dhiman RK, Duseja A, Taneja S, Ning Q, Jia JD, Duan Z, Yu C, Eapen CE, Goel A, Tan SS, Hamid SS, Butt AS, Jafri W, Kim DJ, Hu J, Sood A, Midha V, Shukla A, Ghazinian H, Sahu MK, Treeprasertsuk S, Lee GH, Lim SG, Lesmana LA, Lesmana CR, Shah S, Kalal C, Abbas Z, Sollano JD, Prasad VGM, Payawal DA, Dokmeci AK, Rao PN, Shrestha A, Lau GK, Yuen MF, Saraswat VA, Shiha G, Yokosuka O, Kedarisetty CK, Jain P, Bhatia P, Sarin SK; APASL ACLF working party.

Am J Gastroenterol. 2019 Jun;114(6):929-937. doi: 10.14309/ajg.0000000000000201.

PMID:
31021832
10.

LipidII interaction with specific residues of Mycobacterium tuberculosis PknB extracytoplasmic domain governs its optimal activation.

Kaur P, Rausch M, Malakar B, Watson U, Damle NP, Chawla Y, Srinivasan S, Sharma K, Schneider T, Jhingan GD, Saini D, Mohanty D, Grein F, Nandicoori VK.

Nat Commun. 2019 Mar 15;10(1):1231. doi: 10.1038/s41467-019-09223-9.

11.

Renal Dysfunction in Patients With Nonalcoholic Fatty Liver Disease is Related to the Presence of Diabetes Mellitus and Severity of Liver Disease.

Nampoothiri RV, Duseja A, Rathi M, Agrawal S, Sachdeva N, Mehta M, Dhaliwal HS, Dhiman RK, Chawla Y.

J Clin Exp Hepatol. 2019 Jan-Feb;9(1):22-28. doi: 10.1016/j.jceh.2017.12.005. Epub 2017 Dec 30.

PMID:
30765935
12.

Irreversible Electroporation for Unresectable Hepatocellular Carcinoma: Initial Experience.

Kalra N, Gupta P, Gorsi U, Bhujade H, Chaluvashetty SB, Duseja A, Singh V, Dhiman RK, Chawla YK, Khandelwal N.

Cardiovasc Intervent Radiol. 2019 Apr;42(4):584-590. doi: 10.1007/s00270-019-02164-2. Epub 2019 Jan 29.

PMID:
30697637
13.

Analysis of dengue specific memory B cells, neutralizing antibodies and binding antibodies in healthy adults from India.

Gunisetty S, Nayak K, Chandra Rai R, Chawla Y, Reddy ES, Aggarwal C, Maheshwari D, Panda H, Ansari NA, Singh P, Kaur M, Dixit K, Sharma P, Bhatnagar P, Priyamvada L, Bhaumik SK, Ahamed SF, Vivek R, Ray P, Shet A, Coshic P, Lodha R, Kabra SK, Afroze D, Yousuf A, Ahmed R, Murali-Krishna K, Chandele A.

Int J Infect Dis. 2019 Jul;84S:S57-S63. doi: 10.1016/j.ijid.2019.01.018. Epub 2019 Jan 15.

14.

Vitamin D supplementation in patients with nonalcoholic fatty liver disease: A randomized controlled trial.

Sakpal M, Satsangi S, Mehta M, Duseja A, Bhadada S, Das A, Dhiman RK, Chawla YK.

JGH Open. 2017 Oct 12;1(2):62-67. doi: 10.1002/jgh3.12010. eCollection 2017 Oct.

15.

Invasive fungal infections amongst patients with acute-on-chronic liver failure at high risk for fungal infections.

Verma N, Singh S, Taneja S, Duseja A, Singh V, Dhiman RK, Chakrabarti A, Chawla YK.

Liver Int. 2019 Mar;39(3):503-513. doi: 10.1111/liv.13981. Epub 2018 Oct 24.

PMID:
30276951
16.

Adult onset hereditary hemochromatosis is associated with a novel recurrent Hemojuvelin (HJV) gene mutation in north Indians.

Dhillon BK, Chopra G, Jamwal M, Chandak GR, Duseja A, Malhotra P, Chawla YK, Garewal G, Das R.

Blood Cells Mol Dis. 2018 Nov;73:14-21. doi: 10.1016/j.bcmd.2018.08.003. Epub 2018 Aug 27.

PMID:
30195625
17.

Flare of Autoimmune Hepatitis Causing Acute on Chronic Liver Failure: Diagnosis and Response to Corticosteroid Therapy.

Anand L, Choudhury A, Bihari C, Sharma BC, Kumar M, Maiwall R, Siam Tan S, Shah SR, Hamid S, Butt AS, Jafri W, Chawla YK, Taneja S, Duseja A, Dhiman RK, Mahtab MA, Ghazinyan H, Duan Z, Chen Y, Shukla A, Hu J, Abbas Z, Treeprasertsuk S, Lesmana LA, Lesmana CR, Sollano JD, Carpio G, Sahu MK, Kumar G, Sarin SK; APASL ACLF (APASL ACLF Research Consortium) Working Party.

Hepatology. 2019 Aug;70(2):587-596. doi: 10.1002/hep.30205. Epub 2019 Feb 22.

PMID:
30113706
18.

Monocyte human leukocyte antigen - Antigen D related, neutrophil oxidative burst and cytokine analysis in patients of decompensated cirrhosis with and without acute-on chronic liver failure.

Satsangi S, Duseja A, Sachdeva M, Tomer S, Arora SK, Taneja S, Dhiman RK, Chawla YK.

PLoS One. 2018 Jul 18;13(7):e0200644. doi: 10.1371/journal.pone.0200644. eCollection 2018.

19.

Diagnostic Value of Glypican3, Heat Shock Protein 70 and Glutamine Synthetase in Hepatocellular Carcinoma Arising in Cirrhotic and Non-Cirrhotic Livers.

Uthamalingam P, Das A, Behra A, Kalra N, Chawla Y.

J Clin Exp Hepatol. 2018 Jun;8(2):173-180. doi: 10.1016/j.jceh.2017.09.005. Epub 2017 Oct 7.

20.

Acute Exacerbation to Autoimmune Hepatitis Mimicking Acute Viral Hepatitis-A Case Series and Review of Literature.

Taneja S, Kumar P, Mitra S, Duseja A, Minz R, Das A, Dhiman RK, Chawla Y.

J Clin Exp Hepatol. 2018 Mar;8(1):98-103. doi: 10.1016/j.jceh.2017.08.005. Epub 2017 Sep 1.

21.

A Case of Acute-on-Chronic Liver Failure (ACLF) Due to An Uncommon Acute And Chronic Event.

Agrawal S, Rana BS, Mitra S, Duseja A, Das A, Dhiman RK, Chawla Y.

J Clin Exp Hepatol. 2018 Mar;8(1):95-97. doi: 10.1016/j.jceh.2017.08.006. Epub 2017 Sep 1.

22.

Cost of Intensive Care Treatment for Liver Disorders at Tertiary Care Level in India.

Prinja S, Bahuguna P, Duseja A, Kaur M, Chawla YK.

Pharmacoecon Open. 2018 Jun;2(2):179-190. doi: 10.1007/s41669-017-0041-4.

23.

Comparison of radiofrequency ablation alone & in combination with percutaneous ethanol injection for management of hepatocellular carcinoma.

Kalra N, Kang M, Duseja AK, Bhatia A, Singh V, Dhiman RK, Rajwanshi A, Chawla YK, Khandelwal N.

Indian J Med Res. 2017 Nov;146(Suppl):S30-S37. doi: 10.4103/ijmr.IJMR_1812_15.

24.

The transpeptidase PbpA and noncanonical transglycosylase RodA of Mycobacterium tuberculosis play important roles in regulating bacterial cell lengths.

Arora D, Chawla Y, Malakar B, Singh A, Nandicoori VK.

J Biol Chem. 2018 Apr 27;293(17):6497-6516. doi: 10.1074/jbc.M117.811190. Epub 2018 Mar 12.

25.

Low-Dose Sofosbuvir Is Safe and Effective in Treating Chronic Hepatitis C in Patients with Severe Renal Impairment or End-Stage Renal Disease.

Taneja S, Duseja A, De A, Mehta M, Ramachandran R, Kumar V, Kohli HS, Gupta KL, Dhiman RK, Chawla Y.

Dig Dis Sci. 2018 May;63(5):1334-1340. doi: 10.1007/s10620-018-4979-6. Epub 2018 Feb 26.

PMID:
29484572
26.

Drug idiosyncrasy due to pirfenidone presenting as acute liver failure: Case report and mini-review of the literature.

Verma N, Kumar P, Mitra S, Taneja S, Dhooria S, Das A, Duseja A, Dhiman RK, Chawla Y.

Hepatol Commun. 2017 Dec 27;2(2):142-147. doi: 10.1002/hep4.1133. eCollection 2018 Feb. Review.

27.

Rupture of Hepatocellular Carcinoma: a Tale of 20 Cases from a Tertiary Care Center in Northern India.

Sahu SK, Taneja S, Kalra N, Dhiman RK, Chawla YK, Duseja A, Singh V.

J Gastrointest Cancer. 2019 Sep;50(3):596-600. doi: 10.1007/s12029-018-0063-x. No abstract available.

PMID:
29399732
28.

Association of liver cirrhosis severity with type 2 diabetes mellitus in hepatocellular carcinoma.

Makol A, Kanthaje S, Dhiman RK, Kalra N, Chawla YK, Chakraborti A.

Exp Biol Med (Maywood). 2018 Feb;243(4):323-326. doi: 10.1177/1535370217744511. Epub 2017 Nov 29.

29.

Etiology and mode of presentation of chronic liver diseases in India: A multi centric study.

Mukherjee PS, Vishnubhatla S, Amarapurkar DN, Das K, Sood A, Chawla YK, Eapen CE, Boddu P, Thomas V, Varshney S, Hidangmayum DS, Bhaumik P, Thakur B, Acharya SK, Chowdhury A.

PLoS One. 2017 Oct 26;12(10):e0187033. doi: 10.1371/journal.pone.0187033. eCollection 2017.

30.

Corrigendum to "Indian National Association for Study of the Liver (INASL) guidance for antiviral therapy against HCV infection: Update 2016" [J. Clin. Exp. Hepatol. 6 (2016) 119-145].

Puri P, Saraswat VA, Dhiman RK, Anand AC, Acharya SK, Singh SP, Chawla YK, Amarapurkar DN, Kumar A, Arora A, Dixit VK, Koshy A, Sood A, Duseja A, Kapoor D, Madan K, Srivastava A, Kumar A, Wadhawan M, Goel A, Verma A, Shalimar, Pandey G, Malik R, Agrawal S.

J Clin Exp Hepatol. 2016 Sep;6(3):263. doi: 10.1016/j.jceh.2016.09.009. Epub 2016 Oct 3.

31.

Comparison of Contrast Enhanced Ultrasound With Contrast Enhanced Computed Tomography for the Diagnosis of Hepatocellular Carcinoma.

Moudgil S, Kalra N, Prabhakar N, Dhiman RK, Behera A, Chawla YK, Khandelwal N.

J Clin Exp Hepatol. 2017 Sep;7(3):222-229. doi: 10.1016/j.jceh.2017.03.003. Epub 2017 Mar 16.

32.

Characterization of Cerebral Edema in Acute-on-Chronic Liver Failure.

Gupta T, Dhiman RK, Ahuja CK, Agrawal S, Chopra M, Kalra N, Duseja A, Taneja S, Khandelwal N, Chawla Y.

J Clin Exp Hepatol. 2017 Sep;7(3):190-197. doi: 10.1016/j.jceh.2017.04.001. Epub 2017 Apr 8.

33.

Assessment of Liver Fibrosis by Transient Elastography Should Be Done After Hemodialysis in End Stage Renal Disease Patients with Liver Disease.

Taneja S, Borkakoty A, Rathi S, Kumar V, Duseja A, Dhiman RK, Gupta KL, Chawla Y.

Dig Dis Sci. 2017 Nov;62(11):3186-3192. doi: 10.1007/s10620-017-4777-6. Epub 2017 Sep 25.

PMID:
28948504
34.

Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models.

Choudhury A, Jindal A, Maiwall R, Sharma MK, Sharma BC, Pamecha V, Mahtab M, Rahman S, Chawla YK, Taneja S, Tan SS, Devarbhavi H, Duan Z, Yu C, Ning Q, Jia JD, Amarapurkar D, Eapen CE, Goel A, Hamid SS, Butt AS, Jafri W, Kim DJ, Ghazinian H, Lee GH, Sood A, Lesmana LA, Abbas Z, Shiha G, Payawal DA, Dokmeci AK, Sollano JD, Carpio G, Lau GK, Karim F, Rao PN, Moreau R, Jain P, Bhatia P, Kumar G, Sarin SK; APASL ACLF Working Party.

Hepatol Int. 2017 Sep;11(5):461-471. doi: 10.1007/s12072-017-9816-z. Epub 2017 Aug 30.

PMID:
28856540
35.

Acute Liver Failure Due to Etodolac, a Selective Cycloxygenase- 2 (COX -2) Inhibitor Non-Steroidal Anti-Inflammatory Drug Established by RUCAM-Based Causality Assessment.

Taneja S, Kumar P, Rathi S, Duseja A, Singh V, Dhiman RK, Chawla YK.

Ann Hepatol. 2017 Sep-Oct;16(5):818-821. doi: 10.5604/01.3001.0010.2829.

36.

Successful treatment of chronic hepatitis C infection with directly acting antivirals in renal transplant recipients.

Taneja S, Duseja A, De A, Kumar V, Ramachandran R, Sharma A, Dhiman RK, Gupta KL, Chawla Y.

Nephrology (Carlton). 2018 Sep;23(9):876-882. doi: 10.1111/nep.13109.

PMID:
28703905
37.

The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups.

Chitturi S, Wong VW, Chan WK, Wong GL, Wong SK, Sollano J, Ni YH, Liu CJ, Lin YC, Lesmana LA, Kim SU, Hashimoto E, Hamaguchi M, Goh KL, Fan J, Duseja A, Dan YY, Chawla Y, Farrell G, Chan HL.

J Gastroenterol Hepatol. 2018 Jan;33(1):86-98. doi: 10.1111/jgh.13856. Review. No abstract available.

PMID:
28692197
38.

Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 1: Definition, risk factors and assessment.

Wong VW, Chan WK, Chitturi S, Chawla Y, Dan YY, Duseja A, Fan J, Goh KL, Hamaguchi M, Hashimoto E, Kim SU, Lesmana LA, Lin YC, Liu CJ, Ni YH, Sollano J, Wong SK, Wong GL, Chan HL, Farrell G.

J Gastroenterol Hepatol. 2018 Jan;33(1):70-85. doi: 10.1111/jgh.13857. Review. No abstract available.

PMID:
28670712
39.

Can Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease Co-Exist?

Mehta M, Satsangi S, Duseja A, Taneja S, Dhiman RK, Chawla Y.

J Clin Exp Hepatol. 2017 Jun;7(2):121-126. doi: 10.1016/j.jceh.2017.01.112. Epub 2017 Feb 3.

40.

Spontaneous Bacterial Peritonitis by Burkholderia cepacia Complex: A Rare, Difficult to Treat Infection in Decompensated Cirrhotic Patients.

Taneja S, Kumar P, Gautam V, Duseja A, Singh V, Dhiman RK, Chawla Y.

J Clin Exp Hepatol. 2017 Jun;7(2):102-106. doi: 10.1016/j.jceh.2016.08.008. Epub 2016 Aug 28.

41.

Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, Tateishi R, Han KH, Chawla YK, Shiina S, Jafri W, Payawal DA, Ohki T, Ogasawara S, Chen PJ, Lesmana CRA, Lesmana LA, Gani RA, Obi S, Dokmeci AK, Sarin SK.

Hepatol Int. 2017 Jul;11(4):317-370. doi: 10.1007/s12072-017-9799-9. Epub 2017 Jun 15. Review.

42.

Perioperative use of terlipressin in adult liver transplant.

Taneja S, Chawla YK.

Liver Transpl. 2017 Aug;23(8):995-996. doi: 10.1002/lt.24800. No abstract available.

43.

Vascular endothelial growth factor: Evidence for autocrine signaling in hepatocellular carcinoma cell lines affecting invasion.

Sharma BK, Srinivasan R, Chawla YK, Chakraborti A.

Indian J Cancer. 2016 Oct-Dec;53(4):542-547. doi: 10.4103/0019-509X.204765.

44.

Development of predisposition, injury, response, organ failure model for predicting acute kidney injury in acute on chronic liver failure.

Maiwall R, Sarin SK, Kumar S, Jain P, Kumar G, Bhadoria AS, Moreau R, Kedarisetty CK, Abbas Z, Amarapurkar D, Bhardwaj A, Bihari C, Butt AS, Chan A, Chawla YK, Chowdhury A, Dhiman R, Dokmeci AK, Ghazinyan H, Hamid SS, Kim DJ, Komolmit P, Lau GK, Lee GH, Lesmana LA, Jamwal K, Mamun-Al-Mahtab, Mathur RP, Nayak SL, Ning Q, Pamecha V, Alcantara-Payawal D, Rastogi A, Rahman S, Rela M, Saraswat VA, Shah S, Shiha G, Sharma BC, Sharma MK, Sharma K, Tan SS, Chandel SS, Vashishtha C, Wani ZA, Yuen MF, Yokosuka O, Duseja A, Jafri W, Devarbhavi H, Eapen CE, Goel A, Sood A, Ji J, Duan Z, Chen Y; of the APASL ACLF Research Consortium (AARC) working party.

Liver Int. 2017 Oct;37(10):1497-1507. doi: 10.1111/liv.13443. Epub 2017 Aug 2.

PMID:
28393476
45.

Systemic inflammatory response syndrome in acute-on-chronic liver failure: Relevance of 'golden window': A prospective study.

Choudhury A, Kumar M, Sharma BC, Maiwall R, Pamecha V, Moreau R, Chawla YK, Duseja A, Mahtab M, Rahman S, Hamid SS, Butt AS, Jafri W, Tan SS, Devarbhavi H, Amarapurkar D, Ning Q, Eapen CE, Goel A, Kim DJ, Ghazinyan H, Shiha G, Lee GH, Abbas Z, Payawal DA, Dokmeci AK, Yuen MF, Lesmana LA, Sood A, Chan A, Lau GK, Jia JD, Duan Z, Yu C, Yokosuka O, Jain P, Bhadoria AS, Kumar G, Sarin SK; APASL ACLF working party.

J Gastroenterol Hepatol. 2017 Dec;32(12):1989-1997. doi: 10.1111/jgh.13799.

PMID:
28374414
46.

Unusual Presentation of Tubercular Liver Abscess in an Immune-Competent Adult.

Kumar P, Taneja S, Gupta K, Duseja A, Dhiman RK, Chawla YK.

J Clin Exp Hepatol. 2017 Mar;7(1):77-79. doi: 10.1016/j.jceh.2016.09.011. Epub 2016 Sep 17.

47.

Impact of Hepatic and Extrahepatic Insults on the Outcome of Acute-on-Chronic Liver Failure.

Gupta T, Dhiman RK, Rathi S, Agrawal S, Duseja A, Taneja S, Chawla Y.

J Clin Exp Hepatol. 2017 Mar;7(1):9-15. doi: 10.1016/j.jceh.2016.10.006. Epub 2016 Oct 29.

48.

Acute Liver Failure Due to Etodolac, a Selective Cycloxygenase- 2 (COX -2) Inhibitor Non-Steroidal Anti-Inflammatory Drug Established by RUCAM-Based Causality Assessment.

Taneja S, Kumar P, Rathi S, Duseja A, Singh V, Dhiman RK, Chawla YK.

Ann Hepatol. 2017 Sep - Oct;16(5):818-821. doi: 10.5604/01.3001.0010.2829.

49.

Role of Diffusion Weighted Imaging (DWI) for Hepatocellular Carcinoma (HCC) Detection and its Grading on 3T MRI: A Prospective Study.

Shankar S, Kalra N, Bhatia A, Srinivasan R, Singh P, Dhiman RK, Khandelwal N, Chawla Y.

J Clin Exp Hepatol. 2016 Dec;6(4):303-310. doi: 10.1016/j.jceh.2016.08.012. Epub 2016 Sep 1.

50.

Noninvasive Assessment of Liver Fibrosis By Transient Elastography and FIB4/APRI for Prediction of Treatment Response in Chronic Hepatitis C-An Experience from a Tertiary Care Hospital.

Taneja S, Tohra S, Duseja A, Dhiman RK, Chawla YK.

J Clin Exp Hepatol. 2016 Dec;6(4):282-290. doi: 10.1016/j.jceh.2016.08.001. Epub 2016 Aug 18.

Supplemental Content

Loading ...
Support Center